CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

A federal securities class action has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging that the company and its executives made false and misleading statements about the Fabric Genomics acquisition and overstated the durability of reimbursement rates. On May 4, 2026, GeneDx disclosed missed Q1 results, cut 2026 guidance from $540-555 million to $475-490 million, and took a $31.3 million goodwill impairment charge on the Fabric Genomics acquisition purchased for $36.5 million one year prior. The stock fell over 49% on the news. Investors who purchased GeneDx stock between April 16, 2025 and May 4, 2026 may be eligible to participate in the lawsuit, with a deadline of August 3, 2026 to seek lead plaintiff appointment.